Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3.

R B WarrenJ B HansenKristian ReichC PaulLluis L Puig

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)

Brodalumab treatment resulted in significantly higher levels of skin clearance, longer sustained response and greater cumulative treatment benefit vs. ustekinumab.

Keyphrases

combination therapy
replacement therapy